Lee‐Shing Chang

1.6k total citations · 2 hit papers
17 papers, 1.1k citations indexed

About

Lee‐Shing Chang is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Neurology. According to data from OpenAlex, Lee‐Shing Chang has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Surgery and 3 papers in Neurology. Recurrent topics in Lee‐Shing Chang's work include Diabetes Treatment and Management (7 papers), Diabetes Management and Research (5 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Lee‐Shing Chang is often cited by papers focused on Diabetes Treatment and Management (7 papers), Diabetes Management and Research (5 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Lee‐Shing Chang collaborates with scholars based in United States and China. Lee‐Shing Chang's co-authors include L. Esaki, Le Min, Romualdo Barroso‐Sousa, F. Stephen Hodi, Sara M. Tolaney, Ursula B. Kaiser, Alexander Turchin, Shervin Malmasi, Huabing Zhang and Victor Lei and has published in prestigious journals such as Physical Review Letters, Circulation and Endocrine Reviews.

In The Last Decade

Lee‐Shing Chang

17 papers receiving 1.1k citations

Hit Papers

New Transport Phenomenon in a Semiconductor "Superlattice" 1974 2026 1991 2008 1974 2018 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lee‐Shing Chang United States 10 528 385 284 149 136 17 1.1k
Kenji Motohashi Japan 15 375 0.7× 120 0.3× 123 0.4× 63 0.4× 80 0.6× 121 1.0k
John F. Robinson Canada 24 122 0.2× 376 1.0× 164 0.6× 207 1.4× 75 0.6× 50 2.1k
S. Katayama Japan 16 278 0.5× 198 0.5× 24 0.1× 24 0.2× 277 2.0× 63 964
Heying Duan United States 18 72 0.1× 134 0.3× 208 0.7× 135 0.9× 111 0.8× 69 965
Edward J. Moler United States 16 158 0.3× 72 0.2× 80 0.3× 149 1.0× 188 1.4× 38 956
Minoru Kawashima Japan 17 798 1.5× 752 2.0× 48 0.2× 255 1.7× 347 2.6× 56 1.7k
Cong Mai China 14 106 0.2× 402 1.0× 60 0.2× 17 0.1× 552 4.1× 36 1.0k
L. Li China 14 277 0.5× 144 0.4× 120 0.4× 7 0.0× 64 0.5× 26 820
BR Davidson United Kingdom 16 244 0.5× 198 0.5× 221 0.8× 6 0.0× 98 0.7× 56 990
Katsushi Hashimoto Japan 18 577 1.1× 203 0.5× 28 0.1× 19 0.1× 157 1.2× 55 1.0k

Countries citing papers authored by Lee‐Shing Chang

Since Specialization
Citations

This map shows the geographic impact of Lee‐Shing Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee‐Shing Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee‐Shing Chang more than expected).

Fields of papers citing papers by Lee‐Shing Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee‐Shing Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee‐Shing Chang. The network helps show where Lee‐Shing Chang may publish in the future.

Co-authorship network of co-authors of Lee‐Shing Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Lee‐Shing Chang. A scholar is included among the top collaborators of Lee‐Shing Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lee‐Shing Chang. Lee‐Shing Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Blood, Alexander, Lee‐Shing Chang, Joshua Noone, et al.. (2025). Type 2 diabetes disease and management patterns across a large, diverse healthcare system: Issues and opportunities for guideline-directed therapies. American Heart Journal. 282. 114–124. 2 indexed citations
2.
Chang, Lee‐Shing, et al.. (2024). Enrollment strategies in the era of digital revolution: Experience from a remote health management program. American Heart Journal. 278. 181–185. 2 indexed citations
3.
Blood, Alexander, Lee‐Shing Chang, Samuel Aronson, et al.. (2024). Randomized Evaluation of a Remote Management Program to Improve Guideline-Directed Medical Therapy: The DRIVE Trial. Circulation. 149(23). 1802–1811. 10 indexed citations
5.
Chang, Lee‐Shing, et al.. (2023). Assessment of Sex Disparities in Nonacceptance of Statin Therapy and Low-Density Lipoprotein Cholesterol Levels Among Patients at High Cardiovascular Risk. JAMA Network Open. 6(2). e231047–e231047. 24 indexed citations
6.
Blood, Alexander, Lee‐Shing Chang, Lina Matta, et al.. (2023). Abstract 16304: Contemporary Practice Patterns and Opportunities to Improve Type 2 Diabetes (T2D) Therapy in Patients at Elevated Cardiovascular and/or Kidney Risk. Circulation. 148(Suppl_1). 1 indexed citations
7.
Chang, Lee‐Shing, Shervin Malmasi, Huabing Zhang, et al.. (2021). Patient‐provider discussions of bariatric surgery and subsequent weight changes and receipt of bariatric surgery. Obesity. 29(8). 1338–1346. 6 indexed citations
8.
Vaduganathan, Muthiah, et al.. (2021). Asymptomatic Diabetic Cardiomyopathy: an Underrecognized Entity in Type 2 Diabetes. Current Diabetes Reports. 21(10). 41–41. 20 indexed citations
9.
Wang, Fang, et al.. (2021). Coexistence of Immune Checkpoint Inhibitor-Induced Autoimmune Diabetes and Pancreatitis. Frontiers in Endocrinology. 12. 620522–620522. 14 indexed citations
10.
Chang, Lee‐Shing, Muthiah Vaduganathan, Jorge Plutzky, & Vanita R. Aroda. (2019). Bridging the Gap for Patients with Diabetes and Cardiovascular Disease Through Cardiometabolic Collaboration. Current Diabetes Reports. 19(12). 157–157. 6 indexed citations
11.
Chang, Lee‐Shing, Romualdo Barroso‐Sousa, Sara M. Tolaney, et al.. (2018). Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints. Endocrine Reviews. 40(1). 17–65. 357 indexed citations breakdown →
12.
Malmasi, Shervin, Dmitriy Timerman, Victor Lei, et al.. (2017). Decline of insulin therapy and delays in insulin initiation in people with uncontrolled diabetes mellitus. Diabetic Medicine. 34(11). 1599–1602. 35 indexed citations
13.
Chang, Lee‐Shing & Maria A. Yialamas. (2017). Checkpoint Inhibitor-Associated Hypophysitis. Journal of General Internal Medicine. 33(1). 125–127. 9 indexed citations
14.
Chang, Lee‐Shing, et al.. (2017). A weighty issue: Gender disparities in bariatric surgery counseling. Surgery for Obesity and Related Diseases. 13(10). S187–S188. 2 indexed citations
15.
Malmasi, Shervin, et al.. (2017). Extracting Healthcare Quality Information from Unstructured Data.. PubMed. 2017. 1243–1252. 17 indexed citations
16.
Esaki, L. & Lee‐Shing Chang. (1974). New Transport Phenomenon in a Semiconductor "Superlattice". Physical Review Letters. 33(8). 495–498. 516 indexed citations breakdown →
17.
Chang, Lee‐Shing, et al.. (1973). The Growth of a GaAs–GaAlAs Superlattice. Journal of Vacuum Science and Technology. 10(1). 11–16. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026